Allogeneic Hematopoietic Stem Cell Transplant for Adults over 40 Years Old with Acquired Aplastic Anemia
Hawk Kim(Ulsan College), Chul Won Jung(Samsung Medical Center), Sung Hwa Bae(Daegu Catholic University Medical Center), Kyoo‐Hyung Lee(Asan Medical Center), Jae Youg Kwak(Jeonbuk National University Hospital), Jae-Hoo Park(Ulsan University Hospital), Sung Hyun Kim(Celltrion (South Korea)), Ho Jin Shin(Pusan National University Hospital), Jung Hye Choi(Hanyang University Guri Hospital), Won Sik Lee(Fred Hutch Cancer Center), Sung‐Soo Yoon(Seoul National University Hospital), Jong-Ho Won(Soonchunhyang University Hospital Seoul), Sang Kyun Sohn(Kyungpook National University Hospital), Young Don Joo(Inje University Haeundae Paik Hospital), Byung Soo Kim(Korea University), Myung Soo Hyun(Yeungnam University Medical Center), Sukjoong Oh(Kangbuk Samsung Hospital)
Cited by 17
Related Papers
Gilteritinib or Chemotherapy for Relapsed or Refractory <i>FLT3</i> -Mutated AML
|New England Journal of Medicine|2019|1.3k
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study
|The Lancet|2023|194
The novel AKT inhibitor afuresertib shows favorable safety, pharmacokinetics, and clinical activity in multiple myeloma
|Blood|2014|140